Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile

Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
61 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Bristol-Myers Squibb Company (BMS) is specialty biopharmaceutical company, which focuses on innovative drugs to address unmet medical needs of patients with serious diseases. It discovers, develops, licenses, manufactures, markets and distributes biopharmaceuticals and related healthcare products. Its product line includes chemically-synthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/AIDS and rheumatoid arthritis. The company offers its products across the world through a network of wholesalers, retail pharmacies, hospitals and government entities.

Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent d

  
Source:
Document ID
GDME10D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Bristol-Myers Squibb Company, Medical Equipment, Deals By Year, 2010 to YTD 201652
Bristol-Myers Squibb Company, Medical Equipment Deals By Type, 2010 to YTD 201671
Bristol-Myers Squibb Company, Medical Equipment, Deals By Region, 2010 to YTD 201681
Bristol-Myers Squibb Company, Medical Equipment, Deals By Market, 2010 to YTD 201691
Bristol-Myers Squibb Company, Medical Equipment, Deals Summary, 2010 to YTD 2016102
Bristol-Myers Squibb Company, Medical Equipment, Deal Details1221
  Partnerships121
    HTG Molecular Diagnostics Enters into Research Agreement with Bristol-Myers Squibb121
    SomaLogic Enters into Agreement with Bristol-Myers Squibb131
    Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb141
    InCell Enters Into Co-Development Agreement With Bristol-Myers Squibb151
    Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb161
    Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer's Biomarkers171
    Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development181
    Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb191
    Bristol-Myers Squibb Enters Into Co-Development Agreement With Meso Scale201
    Dako Enters Into Co-Development Agreement With Bristol-Myers211
    Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement222
    Opko Health Enters Into An Agreement With Bristol-Myers Squibb241
    Saladax Biomedical Enters Into Co-Development Agreement With Bristol-Myers Squibb251
  Debt Offering261
    Bristol-Myers Squibb Completes Public Offering Of Senior Unsecured Notes Due 2017 For US$750 Million262
    Bristol-Myers Squibb Completes Public Offering Of 2% Senior Unsecured Notes Due 2022 For US$750 Million282
    Bristol-Myers Squibb Completes Public Offering Of 3.25% Senior Unsecured Notes Due 2042 For US$500 Million302
  Acquisition321
    Bristol-Myers Rumored To Acquire Biogen Idec321
Bristol-Myers Squibb Company - Key Competitors331
Key Employees342
Locations And Subsidiaries368
  Head Office361
  Other Locations &Subsidiaries368
Recent Developments441
Strategy And Business Planning441
May 17, 2016: Bristol-Myers Squibb Opens Expanded Biologics Facility441
Jun 25, 2015: Bristol-Myers Squibb Expands R&D Presence Within Hubs of World Class Science and Innovation451
Financial Announcements461
Jul 28, 2016: Bristol-Myers Squibb Reports Second Quarter Financial Results463
Jan 28, 2016: Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results493
Jul 23, 2015: Bristol-Myers Squibb Reports Second Quarter Financial Results523
Corporate Communications551
Jul 25, 2016: Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head551
Jun 20, 2016: Murdo Gordon Appointed Executive Vice President and Chief Commercial Officer561
Mar 03, 2016: Bristol-Myers Squibb Names Peter J. Arduini to Board of Directors571
Legal and Regulatory581
Apr 27, 2015: Bristol-Myers Squibb Receives Positive CHMP Opinion of New ORENCIA (abatacept) ClickJect Pre-Filled Pen Autoinjector Delivery Device581
Other Significant Developments591
May 19, 2016: Inovalon Announces Agreement with Bristol-Myers Squibb to Focus on Real World Outcomes &Value-Based Contracting Initiatives591
Feb 03, 2016: Bonnie J. Addario Lung Cancer Foundation Honors Bristol-Myers Squibb for Improving and Advancing Breakthrough Treatments for Lung Cancer601
Appendix611
  Methodology611
  About GlobalData611
  Contact Us611
  Disclaimer611

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Bristol-Myers-Squibb-Company-BMY-Medical-Equipment-Deals-and-Alliances-Profile-2148-24077>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Bristol-Myers-Squibb-Company-BMY-Medical-Equipment-Deals-and-Alliances-Profile-2148-24077>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research